Page last updated: 2024-10-26

ebastine and Contact Dermatitis

ebastine has been researched along with Contact Dermatitis in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Ebastine is a long-acting, second-generation selective histamine H(1) receptor antagonist."2.73A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults. ( Antonijoan, RM; Barbanoj, MJ; Esbri, R; Fortea, J; García-Gea, C; Puntes, M; Valle, M, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Solinski, HJ1
Dranchak, P1
Oliphant, E1
Gu, X1
Earnest, TW1
Braisted, J1
Inglese, J1
Hoon, MA1
Antonijoan, RM1
García-Gea, C1
Puntes, M1
Valle, M1
Esbri, R1
Fortea, J1
Barbanoj, MJ1

Trials

1 trial available for ebastine and Contact Dermatitis

ArticleYear
A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
    Clinical drug investigation, 2007, Volume: 27, Issue:7

    Topics: Adult; Butyrophenones; Chemistry, Pharmaceutical; Dermatitis, Contact; Double-Blind Method; Female;

2007

Other Studies

1 other study available for ebastine and Contact Dermatitis

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S

2019